JANE JOHNSON: Open Payments
NPI 1427132877 · GRAND BLANC, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,311 in 181 payments from 24 companies in 2025. Trend: 2023 $3,257 · 2024 $3,389 · 2025 $3,311
Food & beverage: $3,311
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 34 | $467 |
| Bayer Healthcare Pharmaceuticals Inc. | 14 | $298 |
| PFIZER INC. | 16 | $276 |
| Vanda Pharmaceuticals Inc. | 14 | $215 |
| AstraZeneca Pharmaceuticals LP | 10 | $214 |
| Novo Nordisk Inc | 13 | $200 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 11 | $184 |
| Sumitomo Pharma America, Inc. | 9 | $174 |
| Merck Sharp & Dohme LLC | 7 | $163 |
| Exact Sciences Corporation | 8 | $150 |
Products named: Kerendia, FANAPT, REXULTI, XIFAXAN, GEMTESA, VERQUVO, VRAYLAR, NURTEC ODT.
Industry payments across MI — which companies pay providers there.
